US finds vaccine recipient “Pfizer-Bion Tech “There are side effects of almost 4,400 cases, 175 of these cases are of an acute severe allergic reaction.
Xinhua News Agency As reported Wednesday (Jan. 6), the US Centers for Disease Prevention and Control (CDC) reported an adverse event. After vaccination against Pfizer-Biotech’s novel coronavirus (COVID-19) (Pfizer-BioNTech) of nearly 4,400 vaccine people as of Dec. 23, 21 of them confirmed an acute allergic reaction.
The US Food and Drug Administration (FDA) announced emergency approval of the Pfizer-Bion Tech vaccine on Dec. 11, divided into two doses, 21 days apart. 1,893,360 first COV vaccine people as of December 23, 2020.
–
After the US Vaccine Adverse Event (VAERS) report, a total of 4,393 Faiser-ByonTec vaccine participants were reported, 175 of which were reported. Further check that there is a possibility of severe allergic reaction. Which includes severe allergy symptoms
While another 21 vaccine recipients were confirmed to have severe anaphylaxis, including 17 with a history of anaphylaxis or anaphylaxis, 7 out of 17 had a history of anaphylaxis.
Centers point out that anaphylaxis is a life-threatening allergic reaction. Which happens rarely after vaccination Usually symptoms begin within minutes to hours.
The center calls for the COVID-19 vaccination facility to strictly follow the vaccination instructions. This includes vaccine history screening. Provide necessary equipment for allergy treatment Observe symptoms after vaccination for the recommended period. And promptly treat suspected allergens by intramuscular epinephrine injection
– .
